LB-012 - EVALUATION OF GLUCOSE ADMINISTRATION RECOMMENDATION IN BIOEQUIVALENCE STUDIES TO SUPPORT GENERIC ORAL ANTIDIABETIC DRUG DEVELOPMENT.

X. Xi, T. Chan, S. Mahjabeen, H. Boyce, J. Shon, P. Ren, M. Frost, M. Kim, S. Lee; US Food and Drug Administration, Silver Spring, MD, USA.

Presenting Author(s)

Xinyuan Xi, PhD

Orise Fellow
US Food and Drug Administration
bethesda, Maryland, United States